ASC orders cease trade of Afexa Life Sciences shareholder rights plans

CALGARY, Sept. 26, 2011 /CNW/ - The Alberta Securities Commission (ASC) has found that it is in the public interest to cease trade Afexa Life Sciences Inc.'s shareholder rights plans as of 12:01 a.m. MST on September 30, 2011.

An ASC panel issued the cease trade order after considering an application by Paladin Labs Inc.

A copy of the Ceased Trade Order has been posted on the ASC website at www.albertasecurities.com.  The ASC panel will release its written decision at a later date.

The ASC is the regulatory agency responsible for administering the province's securities laws. It is entrusted with fostering a fair and efficient capital market in Alberta and protecting investors.  As a member of the Canadian Securities Administrators, the ASC works to improve, coordinate and harmonize the regulation of Canada's capital markets.

SOURCE Alberta Securities Commission

For further information:

For Media Inquiries: 


Mark Dickey
Senior Communications Advisor
403-297-4481
media@seccom.ab.ca
   
For Investor Inquiries: 
ASC Public Inquiries
Toll Free 1-877-355-4488

 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890